The Elecsys pTau217 test can help doctors assess amyloid pathology in people 55 and older showing signs of cognitive decline ...

Aug 24 (Reuters) - The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help ...

The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.

Slow progress often reflects a surface-level relationship with data that already exists, instead of a data shortage.

A Cary teenager who turned a personal family challenge into groundbreaking scientific research.

EnergizeCare provides Memory Discos and respite support for families navigating an Alzheimer's diagnosis.

The Trump administration’s rollback of DEI-related research is now affecting studies examining Black communities higher risk ...

Explore the key differences between dementia and Alzheimer's disease, including symptoms, progression patterns, underlying ...

Roche’s new blood test can help doctors assess whether amyloid pathology linked to Alzheimer’s disease is likely present.The ...

Ever misplaced your keys and felt a flicker of worry about your brain health? Cognitive decline is something so many of us fear as we age. And while there's no guaranteed way to prevent memory loss, ...

Gardner says women are more likely to have or develop Alzheimer’s disease and men are more likely to develop vascular ...

The FDA has cleared Roche and Eli Lilly’s Elecsys pTau217 blood test to help detect Alzheimer’s disease in adults with ...